By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: European Obesity Market on Track to Show Drug, Device Gains
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Global Healthcare > European Obesity Market on Track to Show Drug, Device Gains
Global Healthcare

European Obesity Market on Track to Show Drug, Device Gains

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
Eurobesity
SHARE

The FDA put a slight dent in forecasts for obesity drugs, with a negative view (and decisions) in 2010 that it now seems to be backing away from.

Having forecasted the obesity market earlier this year and having taken a position that the FDA might well revisit its negative decisions on Contrave, Lorcaserin and Qnexa (especially if additional trial data is submitted to address specific concerns), we still hold that there will be substantial upside in obesity drugs (and devices) over the coming decade.

The FDA put a slight dent in forecasts for obesity drugs, with a negative view (and decisions) in 2010 that it now seems to be backing away from.

Having forecasted the obesity market earlier this year and having taken a position that the FDA might well revisit its negative decisions on Contrave, Lorcaserin and Qnexa (especially if additional trial data is submitted to address specific concerns), we still hold that there will be substantial upside in obesity drugs (and devices) over the coming decade.

This is especially true for Europe which, at least in principle, is unaffected by FDA decisions. Below is our forecast of the obesity products market, by specific drug and device types, for Europe through 2019 (sales in $millions). 

 

Eurobesity

 

Source: MedMarket Diligence, LLC; Report S835.

 

Posted via email from medmarket’s posterous

     

TAGGED:Europeobesity
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

Certified nurses
Global Healthcare

Why We Need More Nurse Practitioners

August 25, 2019
BusinessGlobal HealthcareMedical EducationNews

James Huang, China Forum II Co-Chair, Investigates the Big Trends in Chinese Healthcare

December 21, 2011

Obesity Devices Gain From Drug Woes

February 8, 2011

Obesity Drug Development and Market Outlook

July 18, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?